Shan Gao Guanjing Wei Yanrong Hao
10.3389/pore.2023.1611115
Pathol Oncol Res
2023 Jul 6;29:1611115.
cdk4/6 inhibitors palbociclib adverse events breast cancer vitiligo-like lesions
CC BY
https://pubmed.ncbi.nlm.nih.gov/37483648/
Breast Neoplasms / pathology Vitiligo / chemically induced Vitiligo / drug therapy
Breast Neoplasms / pathology Vitiligo / chemically induced Vitiligo / drug therapy Review Case Reports Antineoplastic Combined Chemotherapy Protocols / therapeutic use Cyclin-Dependent Kinase 4 / metabolism Cyclin-Dependent Kinase 4 / therapeutic use Female Humans Protein Kinase Inhibitors / adverse effects Receptor, ErbB-2 / metabolism palbociclib Cyclin-Dependent Kinase 4 Protein Kinase Inhibitors Receptor, ErbB-2
PMC10358287
37483648
Vitiligo-like lesions induced by cyclin-dependent kinase 4/6 inhibitor Palbociclib: a case report and literature review
2023